CLOV vs SBFMW · rev $1.37B vs rev $34.9M
Clover Health Investments Corp (CLOV) versus Sunshine Biopharma Inc. Warrant (SBFMW) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sunshine Biopharma Inc. Warrant (SBFMW) common stock listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SBFMW revenue for 2024-12-31 was $34.9M. Net income was -$5.1M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. SBFMW currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. SBFMW currently screens at market cap $0.
Not investment advice. Open the CLOV and SBFMW stock pages for the full models.
Not investment advice.